Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5371 to 5385 of 7683 results

  1. Relapse prevention after enforced, temporary quit: How can people who have recently stopped or temporarily abstained from smoking in a smokefree inpatient or treatment environment be best supported after discharge to prevent relapse or to stop permanently?

    Recommendation ID NG209/12 Question Relapse prevention after enforced, temporary quit: How can people who have recently stopped or temporarily

  2. Support for people with mental health conditions to stop smoking: How can people with mental health conditions be supported effectively to stop smoking (at individual and system level)? What are the challenges and opportunities and how can they be addressed?

    Recommendation ID NG209/04 Question Support for people with mental health conditions to stop smoking: How can people with mental health

  3. System leadership and service delivery: How can practitioners, institutions and organisations work together to improve systems leadership that impacts collectively on positive outcomes for children and young people's social, emotional and mental wellbeing?

    Recommendation ID NG223/05 Question System leadership and service delivery: How can practitioners, institutions and organisations work

  4. Further research should ideally be in the form of randomised controlled trials. Details of patient selection, the procedure and long-term outcomes should be reported.

    Recommendation ID IPG766 Question Further research should ideally be in the form of randomised controlled trials. Details of patient selection

  5. What structured group activities are effective at improving interpersonal functioning (social skills) for people with complex psychosis?

    Recommendation ID NG181/4 Question What structured group activities are effective at improving interpersonal functioning (social skills)

  6. Hyperphosphatemia in people with CKD stage 4 or 5: What are people with CKD and their family members and carers views and beliefs about taking oral phosphate binders?

    Recommendation ID NG203/5 Question Hyperphosphatemia in people with CKD stage 4 or 5: What are people with CKD and their family members

  7. What approaches can be used to ensure fathers and grandparents help protect or improve the social and emotional wellbeing of vulnerable children aged under 5 years?

    Recommendation ID PH40/3 Question What approaches can be used to ensure fathers and grandparents help protect or improve the social and

  8. What are the barriers that women experience to achieving blood glucose targets?

    Recommendation ID NG3/3 Question What are the barriers that women experience to achieving blood glucose targets? Any explanatory notes(if

  9. Effective ways of providing information to women with pelvic floor dysfunction: What are best ways to provide information about pelvic floor dysfunction to young women (between 12 and 17 years), and to groups defined by protected characteristics under the Equality Act?

    Recommendation ID NG210/19 Question Effective ways of providing information to women with pelvic floor dysfunction: What are best ways

  10. What are the barriers to, and facilitators for, action and coping strategies among people vulnerable to cold-related illness and death with respect to cold homes (including ventilation)? (This includes self-disconnection when using pre-payment meters.)

    Recommendation ID NG6/2 Question What are the barriers to, and facilitators for, action and coping strategies among people vulnerable to

  11. Addressing health inequalities:- What are the barriers to and facilitators for increasing access to community pharmacy services by underserved groups? How should health and wellbeing interventions be tailored to increase service uptake in underserved groups?

    Recommendation ID NG102/3 Question Addressing health inequalities:- What are the barriers to and facilitators for increasing access to

  12. What are the benefits and harms, and cost effectiveness of routine intraoperative cholangiography in people with low to intermediate risk of common bile duct stones?

    Recommendation ID CG188/2 Question What are the benefits and harms, and cost effectiveness of routine intraoperative cholangiography in